ImmunoDiagnostics Mouse Adiponectin is an enzyme-linked immunosorbent assay (ELISA) for Adiponectin.
Adiponectin is an adipokine exclusively expressed in adipose tissues with potent anti-diabetic, anti-atherogenic and anti-inflammatory functions. In humans, decreased serum adiponectin levels are associated with increased body mass index (BMI), decreased insulin sensitivity, less favorable plasma lipid profiles, increased inflammation and increased risk for the development of type 2 diabetes, hypertension and coronary heart diseases.
Each kit is sufficient for one 96-well plate and contains the following components:
- Microtiter strips (96 wells) – Coated with anti-mouse adiponectin polyclonal antibody, sealed.
- 10×Wash buffer, 40 ml.
- 5×Assay buffer, 25 ml.
- 100×Detection antibody solution – A polyclonal antibody against mouse adiponectin conjugated with horseradish peroxidase, 0.12ml.
- Mouse adiponectin standard – 200ng of recombinant mouse adiponectin in a buffered protein base, lyophilized.
- Substrate solution, 12ml, ready for use.
- Stop solution, 12ml, ready for use.
Other Materials Required, But Not Provided
- Pipettes and pipette tips.
- 96-well plate or manual strip washer.
- Buffer and reagent reservoirs.
- Paper towels or absorbent paper.
- Plate reader capable of reading absorbency at 450nm.
- Distilled water or deionized water.
The kit should be stored at 2-8°C upon receipt, and all reagents should be equilibrated to room temperature before use. Remove any unused antibody-coated strips from the mouse adiponectin microplate, return them to the foil pouch and reseal. Once opened, the strips may be stored at 2-8°C for up to one month.
Preparation of Reagents
Bring all reagents and materials to room temperature before assay.
- 1×Assay buffer
Prepare 1×Assay buffer by mixing the 5×Assay buffer (25ml) with 100ml of distilled water or deionized water. If precipitates are observed in the 5×Assay buffer bottle, warm the bottle in a 37°C water bath until the precipitates disappear. The 1×Assay buffer may be stored at 2-8°C for up to one month.
- 1×Wash buffer
Prepare 1×Wash buffer by mixing the 10×Wash buffer (40ml) with 360ml of distilled water or deionized water. The 1×Wash buffer may be stored at 2-8°C for up to one month.
- 1×Detection antibody solution
Spin down the 100×Detection antibody solution briefly and dilute the desired amount of the antibody 1:100 with 1×Assay buffer, 100µl of the 1×Detection antibody solution is required per well. Prepare only as much 1×Detection antibody solution as needed. Return the 100×Detection antibody solution to 2-8°C immediately after the necessary volume is removed.
Preparation of Standards and Samples
Mouse Adiponectin Standards: Reconstitute the lyophilized standard with 1ml of 1×Assay buffer to generate a standard stock solution of 200ng/ml. Allow the standard to sit for 10 minutes with gentle agitation prior to making dilutions. Prepare serially diluted standards using 1×Assay buffer as follows:
|Standard Volume||Volume of 1×Assay buffer||Concentration|
|250µl of 200ng/ml stock||250µl||100ng/ml|
|250µl of 100ng/ml std||250µl||50 ng/ml|
|250µl of 50ng/ml std||250µl||25ng/ml|
|250µl of 25ng/ml std||250µl||12.5ng/ml|
|250µl of 12.5ng/ml std||250µl||6.25ng/ml|
|250µl of 6.25ng/ml std||250µl||3.12ng/ml|
1×Assay buffer serves as the zero standard (0ng/ml). The reconstituted standard stock should be aliquoted and frozen at -20ºC for one month. Avoid repeating freezing/thawing cycles. Please do not store the diluted standard solutions.
Serum or plasma sample is generally required a 400-fold dilution with 1×Assay buffer.
Option 1 (One-step dilution) – Add 2µl of sample to 798µl of 1×Assay buffer to give a 400-fold diluted sample solution.
Option 2 (Two-step dilution) – Add 10µl of sample to 190µl of 1×Assay buffer to give a 20-fold diluted sample solution. Add 20µl of the 20-fold diluted sample solution to 380µl of 1×Assay buffer to give a final 400-fold diluted sample solution. Cellular extract and culture media dilutions will vary and need to be optimized by the user, also use 1×Assay buffer to prepare these samples.
The lowest level of mouse adiponectin that can be detected by this assay is 3.12ng/ml.
The antibodies used in this assay are specific to mouse adiponectin and do not cross-react with human adiponectin, and other cytokine or hormone molecules.
This assay is a sandwich ELISA using affinity-purified polyclonal antibodies against mouse adiponectin. The immunoplate is pre-coated with anti-mouse adiponectin capture antibody. Standards and samples are pipetted into the wells and any mouse adiponectin present is bound by the immobilized antibody. After washing away any unbound substances, a horseradish peroxidase (HRP)-linked polyclonal antibody specific for mouse adiponectin is added to the wells. After a final wash step, an HRP substrate solution is added and color develops in proportion to the amount of mouse adiponectin bound initially. The assay is stopped and the optical density of the wells determined using a microplate reader. Since the increases in absorbance are directly proportional to the amount of captured mouse adiponectin, the unknown sample concentration can be interpolated from a reference curve included in each assay.
It is recommended that all standards and samples be assayed in duplicate.
- Add 100µl of standard or sample per well, incubate at room temperature for 1 hour.
- Discard the content and tap the plate on a clean paper towel to remove residual solution in each well. Add 300µl of 1×Wash buffer to each well and incubate for 1 minute. Discard the 1×Wash buffer and tap the plate on a clean paper towel to remove residual wash buffer. Repeat the wash step for a total 3 washes.
- Add 100µl of 1×Detection antibody solution to each well, incubate at room temperature for 1 hour.
- Wash each well 4 times as described in step 2.
- Add 100µl of Substrate solution to each well, incubate at room temperature for 15 minutes. Protect from light.
- Add 100µl of Stop solution to each well. Gently tap the plate to ensure thorough mixing.
- Measure absorbance of each well at 450nm immediately.
- Subtract the absorbance of the blank from that of standards and samples.
- Generate a standard curve by plotting the absorbance obtained (y-axis) against mouse adiponectin concentrations (x-axis). The best fit line can be generated with any curve-fitting software by regression analysis. Any curve of 4-parameter or log-log curve fitting can be used for calculation.
- Determine mouse adiponectin concentration of samples from standard curve and multiply the value by the dilution factor.
Assay Procedure Summary
Add 100µl of Standard or sample to each well.
Incubate at room temperature for 1 hour.
Aspirate and wash each well 3 times.
Add 100µl of 1×Detection antibody solution to each well.
Incubate at room temperature for 1 hour.
Aspirate and wash each well 4 times.
Add 100µl of Substrate solution to each well.
Incubate at room temperature for 15 minutes.
Add 100µl of Stop solution to each well.
Measure absorbance of each well at 450nm.
Typical Standard Curve
The following standard curve is provided for demonstration only. A standard curve should be generated for each set of sample assay.
|Adiponectin (ng/ml)||Absorbance (450 nm)||Blanked Absorbance|
Mouse adiponectin standard curve (4-parameter)
Adiponectin, also known as apM1, Acrp30, GBP28 and adipoQ, is a circulating hormone predominantly produced from adipose tissue. Many pharmacological studies demonstrated that this protein possesses potent anti-diabetic, anti-atherogenic and anti-inflammatory functions. Supplement of adiponectin protein can decrease blood glucose, improve insulin sensitivity, alleviate fatty liver and prevent atherosclerosis. The protein is posttranslationally modified by hydroxylation and glycosylation, and forms three different oligomeric complexes in the circulation. Many clinical studies demonstrated that plasma adiponectin is a useful biomarker for metabolic syndrome, nonalcoholic steatohepatitis and certain type of cancers. Decreased circulating levels of plasma adiponectin (hypoadiponectinaemia) are associated with increased body mass index (BMI), decreased insulin sensitivity, less favorable plasma lipid profiles, increased levels of inflammatory markers and increased risk for the development of type 2 diabetes, hypertension, and coronary heart diseases. Low adiponectin concentrations were found to be predictive of a future reduction in insulin sensitivity and cardiovascular disorders. Administration of the anti-diabetic drugs thiazolidinediones (TZDs) raises circulating adiponectin levels. In addition, low plasma adiponectin levels are also associated with nonalcoholic steatohepatitis (NASH) and certain types of cancers.
Search this site for “ImmunoDiagnostics”